Cryogenic OGS revises FY26 half-year results; full-year profit up 67%

Cryogenic OGS Limited has filed revised audited financial results for FY26 with BSE, correcting a clerical error in the deferred tax expense for the half-year ended 31 March 2026. The revision impacts the net profit after tax for the half-year period, while full-year figures remain unchanged from the original submission. The Board of Directors approved the revised results at a meeting held on 30 April 2026.

Financial Performance Summary

For the full year ended 31 March 2026, the company reported total revenue of ₹4243.48 lakh, representing a 24% increase from ₹3379.14 lakh in FY25. Revenue from operations stood at ₹4082.24 lakh, with other income contributing ₹161.24 lakh. Profit after tax for FY26 increased to ₹1018.27 lakh, up 67% from ₹608.98 lakh in the previous year. The company reported an exceptional item of ₹123.95 lakh as profit on sale of plot during the year.

Particulars	Year ended 31/03/2026	Year ended 31/03/2025	Half Year ended 31/03/2026 (Revised)
Total Revenue	₹4243.48 lakh	₹3379.14 lakh	₹2072.22 lakh
Total Expenses	₹3018.25 lakh	₹2552.36 lakh	₹1451.01 lakh
Profit before Tax	₹1349.18 lakh	₹826.79 lakh	₹621.22 lakh
Profit after Tax	₹1018.27 lakh	₹608.98 lakh	₹466.60 lakh
Basic EPS	₹7.69	₹5.80	₹3.17

Half-Year Revision Details

The revised submission corrects an error in reporting deferred tax expense for the half-year ended 31 March 2026. Consequently, the profit after tax for the half-year has been revised to ₹466.60 lakh from the previously reported ₹447.22 lakh. The deferred tax adjustment for the half-year shows a negative figure of ₹35.26 lakh, compared to a positive ₹19.38 lakh in the unaudited half-year ended 30 September 2025. The company confirmed that except for this rectification, there are no other changes in the financial results originally submitted.

Balance Sheet and Cash Flow Position

The company's balance sheet strengthened significantly with shareholders' funds growing to ₹5465.18 lakh as of 31 March 2026, compared to ₹2898.60 lakh in the previous year. Share capital increased to ₹1428.00 lakh from ₹1050.00 lakh, while reserves and surplus rose to ₹4037.18 lakh from ₹1848.60 lakh. Cash and cash equivalents surged to ₹3278.24 lakh from ₹1106.67 lakh. Net cash from operating activities improved to ₹798.59 lakh in FY26 from ₹193.55 lakh in the previous year. The company raised ₹1548.31 lakh through issue of shares during the year.

Parameter	As at 31st March 2026	As at 31st March 2025
Shareholders' Funds	₹5465.18 lakh	₹2898.60 lakh
Share Capital	₹1428.00 lakh	₹1050.00 lakh
Cash & Cash Equivalents	₹3278.24 lakh	₹1106.67 lakh
Total Assets	₹6671.75 lakh	₹3385.41 lakh

Auditor's Report

M/s Maloo Bhatt & Co., Chartered Accountants, provided an unmodified opinion on the revised audited financial results. The audit report confirmed that the financial results are presented in accordance with Regulation 33 of SEBI Listing Regulations and give a true and fair view of the company's financial performance for FY26. The auditor noted that the half-year results represent balancing figures between audited full-year figures and unaudited year-to-date figures up to 30 September 2025.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+1.76%	-5.85%	+15.86%	+1.03%	+115.44%	+115.44%

Cryogenic OGS Limited has submitted its compliance statement to BSE Limited regarding the utilization of funds raised through its initial public offering, confirming no deviations from the approved allocation for the half-year ended March 31, 2026. The statement, filed under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, was reviewed and approved by the company's audit committee and board of directors on April 30, 2026.

IPO Fund Details and Allocation

The company raised ₹17.76 crores through its initial public offer completed on July 10, 2025. The funds were allocated across three specific objectives as outlined in the original prospectus.

Parameter	Details
Mode of Fund Raising	Initial Public Offer
Date of Fund Raising	July 10, 2025
Total Amount Raised	₹17.76 Crores
Reporting Period	Half-year ended March 31, 2026
Deviation Status	No

Fund Utilization Breakdown

The detailed utilization of IPO proceeds shows systematic deployment across the three approved categories. The company has utilized funds progressively towards its stated objectives without any modifications to the original allocation.

Object of Issue	Original Allocation (₹ Lakhs)	Funds Utilized (₹ Lakhs)	Status
Working Capital Requirements	1150.00	240.12	On Track
General Corporate Purpose	396.47	284.31	On Track
Issue Related Expenses	230.13	228.29	Nearly Complete

Compliance and Oversight

The fund utilization statement confirms that no monitoring agency oversight is required for this fundraising. Both the audit committee and external auditors have provided no adverse comments on the fund deployment strategy. The company has maintained transparency by making the statement available on its official website at cryogenicogs.com.

Corporate Governance

The statement was signed by Managing Director Nilesh Patel (DIN: 01368574) and Company Secretary & Compliance Officer Rashmi Kamlesh Otavani, demonstrating proper corporate governance protocols. The document confirms that no shareholder approval was required for any changes in fund utilization as no deviations occurred from the original objects of the issue.